Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/26/25 18:45 | 11/24/25 | SION | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | D | 1 | S.m | -4,814 | 44.55 | 0 | -108 | 3,597 | I | ||||||||||||||||
11/26/25 18:41 | 11/24/25 | SION | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | MA | D | 1 | S.m | -4,814 | 44.55 | 0 | -108 | 3,597 | I | ||||||||||||||||
11/24/25 17:43 | 11/20/25 | SION | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | 3 | S.m | -21,463 | 39.73 | 0 | -540 | 209 | I | ||||||||||||||||
10/22/25 17:39 | 10/21/25 | SION | Health | Drug | Pharmaceutical Preparations | Cloonan Michael | MA | DO | P,CEO | 3 | S.dm | -5,135 | 34.23 | 0 | -150 | 547 | D | |||||||||||||||
10/21/25 17:12 | 10/21/25 | SION | Health | Drug | Pharmaceutical Preparations | Booth Bruce | MA | D | 5 | S.m | -22,086 | 31.62 | 0 | -698 | 3,615 | I | ||||||||||||||||
9/5/25 16:03 | 9/4/25 | SION | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Jennifer | MA | O | GC | 1 | S.d | -237 | 23.12 | 0 | -10 | -100 | 0 | D | ||||||||||||||
9/3/25 17:16 | 8/29/25 | SION | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | MA | O | CFO,Head | 1 | S.m | -240 | 25.09 | 0 | -10 | 39 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |